ArticleThe oncologist2023

Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors.

Jordyn Silverstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.